MAZE
Maze Therapeutics, Inc.
36.73
+1.28 (+3.61%)
52w low 21.95
53.65 high
46.6% of range
Financial Analysis
| (USD) | Dec 22 | Dec 23 | Dec 24 | Dec 25 | Trend |
|---|---|---|---|---|---|
| Operating Cash Flow | -99.20M | -86.83M | 75.95M | -111.94M | |
| Depreciation & Amort | 3.82M | 4.09M | 3.30M | 2.40M | |
| Capital Expenditure | -1.97M | -441.00K | -1.15M | -794.00K | |
| Free Cash Flow | -101.17M | -87.27M | 74.81M | -112.73M | |
| Investing Cash Flow | -3.17M | -441.00K | -1.15M | -170.96M | |
| Financing Cash Flow | 1.73M | 16.39M | 92.85M | 275.34M |
Revenue CAGR
--
Net Income CAGR
--
EPS CAGR
--
FCF CAGR
--
Revenue YoY
-100.0%